Announcement on behalf of AP Biosciences of the BOD’s resolution to issue common shares through cash capital increase and the reference date

1.Date of the resolution by the board of directors or decision by the Company:2022/06/22 2.Number of shares issued:16,000,000 common shares 3.Par value per share:10 NTD 4.Total monetary value of the …

Announcement on behalf of Amaran of important resolutions of the 2022 annual shareholders’ meeting

1.Date of the shareholders’ meeting:2022/06/16 2.Important resolutions I.Profit distribution/deficit compensation:Acknowledgement of the 2021 Deficit Compensation. 3.Important resolutions II.Amendments of the company charter:None 4.Important resolutions III.Business report and financial statements:Acknowledgement of …

Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, and OBI-3424

Title: A phase 3, randomized, open-label study of the anti-Globo H vaccine Adagloxad Simolenin/OBI-821 in the adjuvant treatment of high-risk, early-stage, Globo H-positive triple-negative breast cancer. Poster / Abstract number: …

OBI Pharma Announces Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, OBI-3424, and Exhibition Booth

Poster Presentations to highlight the ongoing clinical studies targeting Globo H and AKR1C3 OBI Pharma, Inc. (TPEx: 4174), a leader in First-in-Class Cancer therapeutics, today announced that data highlighting ongoing …

Announcement on behalf of AP Biosciences of resolution of the Ex-rights record date of new shares through capitalization of capital surplus

1.Date of the resolution by the board of directors or shareholders’ meeting or decision by the Company:2022/05/13 2.Type of ex-rights or ex-dividend (please enter: “Ex-rights”, ”Ex-dividend”, or ”Ex-rights and dividend”):Ex-rights …

Announcement on behalf of AP Biosciences of important resolutions of the 2022 annual shareholders’ meeting

1.Date of the shareholders’ meeting:2022/05/13 2.Important resolutions I.Profit distribution/deficit compensation:Acknowledgement of the 2021 Earnings Distribution Loss Off-setting 3.Important resolutions II.Amendments of the company charter:None 4.Important resolutions III.Business report and financial …

The Company’s Board of Directors resolved to rent office space in Taipei Bioinnovation Park

1.Name and nature of the underlying asset (e.g., land located at Sublot XX, Lot XX, North District, Taichung City): 5th and 6th floor of Taipei Bioinnovation Park (located at Sublot …

The Company’s Board of Directors approved 2022 Restricted Stock Awards and the Issuance Rules

1.Resolution date of the board of directors:2022/05/06 2.Expected issue price:Grants will be made free of charge with an issue price per share of NT$0. 3.Expected total amount (shares) of issuance:A …

The Company’s Board of Directors resolved to convene the 2022 Annual General Shareholders’ Meeting (Change of location and new approval)

1.Date of the board of directors resolution:2022/05/06 2.General shareholders’ meeting date:2022/06/27 3.General shareholders’ meeting location:Courtyard Taipei, Supernova ballroom, 7th Floor (7th Floor, No. 359, Section 7, Zhongxiao East Road, Sedative …

Announcement of the Consolidated Financial Statements for the first quarter of 2022 were approved by the Board of Directors

1.Date of the board of directors submitted or approved:2022/05/06 2.Date of the audit committee approved:2022/05/06 3.Start and end dates of financial reports or unaudited financial information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):2022/01/01~2022/03/31 …